Bangladesh Health Times
SEE OTHER BRANDS

Get your health and wellness news from Bangladesh

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Bangladesh Health Times.

D’Art Accomplishes a Milestone of 60,000 Retail Touchpoints Across Diverse Markets
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
ICRAPAIN 2025 in Kolkata Brings Together Global Experts in Pain Medicine
Bangladesh Reports Over 100 Fatalities in Dengue Fever
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents
Dengue Death Toll in Bangladesh Increases
Dengue death toll in Bangladesh reaches one hundred one
Bangladesh Air Force Jet Crash Claims 27 Lives
Bangladesh Air Force jet crashes into college campus
Bangladesh Reports 19 Dead as Air Force Jet Crashes into College
WHO cautions of increase of chikungunya disease
Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
Air Force Plane Crash in Bangladesh Claims 27 Lives
DR. ERIKA WICHRO SELECTED FOR TOP INSPIRATIONAL LEADER OF THE YEAR IN HEALTH BY IAOTP
Samitivej Hospital Bangladesh Office Supports Growing Number of Patients Seeking Treatment in Thailand
Healthcare Data Analyst Tashin Azad of Centene Corporation Recently Featured on Close Up Radio
Media Bangladesh - MediaBangladesh.net Transforms into a Global All-Niche Informative Platform
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions